Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
Article first published online: 16 MAR 2011
© 2011 John Wiley & Sons A/S
Volume 31, Issue 5, pages 676–684, May 2011
How to Cite
Gane, E. J., Wang, Y., Liaw, Y.-F., Hou, J., Thongsawat, S., Wan, M., Moon, Y. M., Jia, J., Chao, Y. C., Niu, J., Leung, N., Samuel, D., Hsu, C. W., Bao, W., Lopez, P. and Avila, C. (2011), Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. Liver International, 31: 676–684. doi: 10.1111/j.1478-3231.2011.02490.x
- Issue published online: 3 APR 2011
- Article first published online: 16 MAR 2011
- Received 17 May 2010, Accepted 3 February 2011
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.